Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis (ChIP-seq)
Ontology highlight
ABSTRACT: Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis (ChIP-seq)
OTHER RELATED OMICS DATASETS IN: GSE59591
PROVIDER: PRJNA255661 | ENA |
REPOSITORIES: ENA
ACCESS DATA